Showing results (2011-2020 of 3,978) with videos related to
Sort By:
Pageof 398
European Journal of Heart Failure|November 5, 2002
Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left-ventricular systolic heart failureBjoern A Groenning, Jens C Nilsson, Per R Hildebrandt, et al.European Journal of Heart Failure|November 5, 2002
Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)M Echemann, F Alla, S Briançon, et al.European Journal of Heart Failure|August 11, 2000
No evidence for systolic or diastolic left ventricular dysfunction at rest in selected patients with long-term type I diabetes mellitusM Romanens, S Fankhauser, B Saner, et al.European Journal of Heart Failure|August 11, 2000
The carvedilol hibernation reversible ischaemia trial; marker of success (CHRISTMAS). The CHRISTMAS Study Steering Committee and InvestigatorsJ G Cleland, D Pennel, S Ray, et al.European Journal of Heart Failure|August 11, 2000
Angiotensin-II type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failureB Andersson, I Blange, C SylvénEuropean Journal of Heart Failure|August 11, 2000
Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the ElderlyA R Houghton, M Harrison, A J CowleyEuropean Journal of Heart Failure|August 11, 2000
Diagnostic tests, treatment and follow-up in heart failure patients--is there a gender bias in the coherence to guidelines?M Mejhert, J Holmgren, P Wändell, et al.European Journal of Heart Failure|August 11, 2000
Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failureD B Northridge, P F Currie, D E Newby, et al.European Journal of Heart Failure|August 11, 2000
Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival studyJ G Cleland, P Armstrong, J D Horowitz, et al.Pageof 398